APA (7th ed.) Citation

F, A., M, D., C, Q., F, L. B., T, A., A, D., . . . JM, M. (2023). Precision Medicine Approach Based on Molecular Alterations for Patients with Relapsed or Refractory Multiple Myeloma: Results from the MM-EP1 Study. Cancers, 15(5), . https://doi.org/10.3390/cancers15051508

Chicago Style (17th ed.) Citation

F, Andreozzi, et al. "Precision Medicine Approach Based on Molecular Alterations for Patients with Relapsed or Refractory Multiple Myeloma: Results from the MM-EP1 Study." Cancers 15, no. 5 (2023). https://doi.org/10.3390/cancers15051508.

MLA (9th ed.) Citation

F, Andreozzi, et al. "Precision Medicine Approach Based on Molecular Alterations for Patients with Relapsed or Refractory Multiple Myeloma: Results from the MM-EP1 Study." Cancers, vol. 15, no. 5, 2023, https://doi.org/10.3390/cancers15051508.